Annual Cash & Cash Equivalents
$85.22 M
+$14.83 M+21.07%
March 31, 2024
Summary
- As of February 26, 2025, RDY annual cash & cash equivalents is $85.22 million, with the most recent change of +$14.83 million (+21.07%) on March 31, 2024.
- During the last 3 years, RDY annual cash & cash equivalents has fallen by -$116.68 million (-57.79%).
- RDY annual cash & cash equivalents is now -79.65% below its all-time high of $418.74 million, reached on March 31, 2007.
Performance
RDY Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$143.25 M
+$7.92 M+5.85%
December 31, 2024
Summary
- As of February 26, 2025, RDY quarterly cash and cash equivalents is $143.25 million, with the most recent change of +$7.92 million (+5.85%) on December 31, 2024.
- Over the past year, RDY quarterly cash and cash equivalents has increased by +$55.30 million (+62.88%).
- RDY quarterly cash and cash equivalents is now -65.79% below its all-time high of $418.74 million, reached on March 31, 2007.
Performance
RDY Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RDY Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +21.1% | +62.9% |
| 3 y3 years | -57.8% | -26.9% |
| 5 y5 years | +165.6% | -26.9% |
RDY Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -57.8% | +21.1% | -51.5% | +143.3% |
| 5 y | 5-year | -57.8% | +213.1% | -51.5% | +426.3% |
| alltime | all time | -79.7% | +725.5% | -65.8% | +485.3% |
Dr Reddys Laboratories Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $143.25 M(+5.8%) |
| Sep 2024 | - | $135.34 M(+129.9%) |
| Jun 2024 | - | $58.87 M(-30.9%) |
| Mar 2024 | $85.22 M(+21.1%) | $85.22 M(-3.1%) |
| Dec 2023 | - | $87.95 M(-45.4%) |
| Sep 2023 | - | $160.93 M(+119.5%) |
| Jun 2023 | - | $73.31 M(+4.2%) |
| Mar 2023 | $70.39 M(-64.1%) | $70.39 M(-6.9%) |
| Dec 2022 | - | $75.63 M(-32.3%) |
| Sep 2022 | - | $111.64 M(+46.4%) |
| Jun 2022 | - | $76.27 M(-61.1%) |
| Mar 2022 | $195.87 M(-3.0%) | $195.87 M(-33.7%) |
| Dec 2021 | - | $295.25 M(+119.9%) |
| Sep 2021 | - | $134.28 M(+22.1%) |
| Jun 2021 | - | $109.95 M(-45.5%) |
| Mar 2021 | $201.90 M(+641.7%) | $201.90 M(+243.2%) |
| Dec 2020 | - | $58.83 M(+12.1%) |
| Sep 2020 | - | $52.49 M(-9.6%) |
| Jun 2020 | - | $58.09 M(+113.4%) |
| Mar 2020 | $27.22 M(-15.2%) | $27.22 M(-13.2%) |
| Dec 2019 | - | $31.36 M(-26.6%) |
| Sep 2019 | - | $42.71 M(+43.3%) |
| Jun 2019 | - | $29.81 M(-7.1%) |
| Mar 2019 | $32.08 M(-20.8%) | $32.08 M(+31.1%) |
| Dec 2018 | - | $24.48 M(-53.0%) |
| Sep 2018 | - | $52.12 M(+63.7%) |
| Jun 2018 | - | $31.85 M(-21.4%) |
| Mar 2018 | $40.52 M(-32.0%) | $40.52 M(+28.7%) |
| Dec 2017 | - | $31.48 M(-16.4%) |
| Sep 2017 | - | $37.64 M(-13.7%) |
| Jun 2017 | - | $43.59 M(-26.9%) |
| Mar 2017 | $59.61 M(-19.6%) | $59.61 M(-32.8%) |
| Dec 2016 | - | $88.78 M(+142.9%) |
| Sep 2016 | - | $36.55 M(-61.1%) |
| Jun 2016 | - | $93.93 M(+26.7%) |
| Mar 2016 | $74.11 M(-14.1%) | $74.11 M(-16.5%) |
| Dec 2015 | - | $88.78 M(-12.4%) |
| Sep 2015 | - | $101.35 M(+2.6%) |
| Jun 2015 | - | $98.78 M(+14.5%) |
| Mar 2015 | $86.25 M(-38.9%) | $86.25 M(-12.9%) |
| Dec 2014 | - | $99.00 M(-25.8%) |
| Sep 2014 | - | $133.43 M(+23.1%) |
| Jun 2014 | - | $108.39 M(-23.2%) |
| Mar 2014 | $141.22 M(+49.6%) | $141.22 M(-58.9%) |
| Dec 2013 | - | $343.58 M(+87.7%) |
| Sep 2013 | - | $183.07 M(+21.4%) |
| Jun 2013 | - | $150.77 M(+59.7%) |
| Mar 2013 | $94.40 M | $94.40 M(-41.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $160.36 M(+21.8%) |
| Sep 2012 | - | $131.62 M(-11.7%) |
| Jun 2012 | - | $149.00 M(+3.7%) |
| Mar 2012 | $143.67 M(+12.0%) | $143.67 M(-54.1%) |
| Dec 2011 | - | $312.66 M(+101.3%) |
| Sep 2011 | - | $155.34 M(+27.3%) |
| Jun 2011 | - | $121.99 M(-4.9%) |
| Mar 2011 | $128.33 M(-12.6%) | $128.33 M(+39.5%) |
| Dec 2010 | - | $92.01 M(-33.6%) |
| Sep 2010 | - | $138.48 M(+1.1%) |
| Jun 2010 | - | $137.00 M(-6.7%) |
| Mar 2010 | $146.76 M(+32.9%) | $146.76 M(+23.0%) |
| Dec 2009 | - | $119.31 M(-7.2%) |
| Sep 2009 | - | $128.51 M(-0.8%) |
| Jun 2009 | - | $129.49 M(+17.3%) |
| Mar 2009 | $110.41 M(-40.3%) | $110.41 M(+40.3%) |
| Dec 2008 | - | $78.67 M(-28.6%) |
| Sep 2008 | - | $110.14 M(+27.4%) |
| Jun 2008 | - | $86.47 M(-53.3%) |
| Mar 2008 | $185.01 M(-55.8%) | $185.01 M(+16.2%) |
| Dec 2007 | - | $159.26 M(-25.2%) |
| Sep 2007 | - | $212.99 M(-22.3%) |
| Jun 2007 | - | $274.19 M(-34.5%) |
| Mar 2007 | $418.74 M(+400.9%) | $418.74 M(+10.8%) |
| Dec 2006 | - | $377.89 M(+255.5%) |
| Sep 2006 | - | $106.29 M(+41.4%) |
| Jun 2006 | - | $75.17 M(-10.1%) |
| Mar 2006 | $83.59 M(-60.8%) | $83.59 M(-53.8%) |
| Dec 2005 | - | $180.99 M(-24.7%) |
| Sep 2005 | - | $240.51 M(+0.9%) |
| Jun 2005 | - | $238.47 M(+12.0%) |
| Mar 2005 | $212.98 M(+110.4%) | $212.98 M(+61.7%) |
| Dec 2004 | - | $131.74 M(+9.0%) |
| Sep 2004 | - | $120.83 M(+34.1%) |
| Jun 2004 | - | $90.07 M(-11.0%) |
| Mar 2004 | $101.21 M(-32.5%) | $101.21 M(-20.3%) |
| Dec 2003 | - | $126.97 M(-23.8%) |
| Sep 2003 | - | $166.55 M(+0.8%) |
| Jun 2003 | - | $165.25 M(+10.2%) |
| Mar 2003 | $149.96 M(+43.2%) | $149.96 M(+4.3%) |
| Dec 2002 | - | $143.74 M(+7.0%) |
| Sep 2002 | - | $134.28 M(+3.8%) |
| Jun 2002 | - | $129.32 M(+23.5%) |
| Mar 2002 | $104.70 M(+914.2%) | $104.70 M(+26.0%) |
| Dec 2001 | - | $83.08 M(+29.6%) |
| Sep 2001 | - | $64.11 M(-4.5%) |
| Jun 2001 | - | $67.15 M |
| Mar 2001 | $10.32 M | - |
FAQ
- What is Dr Reddys Laboratories Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual cash & cash equivalents year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly cash and cash equivalents year-on-year change?
What is Dr Reddys Laboratories Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of RDY is $85.22 M
What is the all time high annual cash & cash equivalents for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual cash & cash equivalents is $418.74 M
What is Dr Reddys Laboratories Limited annual cash & cash equivalents year-on-year change?
Over the past year, RDY annual cash & cash equivalents has changed by +$14.83 M (+21.07%)
What is Dr Reddys Laboratories Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RDY is $143.25 M
What is the all time high quarterly cash and cash equivalents for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly cash and cash equivalents is $418.74 M
What is Dr Reddys Laboratories Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, RDY quarterly cash and cash equivalents has changed by +$55.30 M (+62.88%)